Testsealabs CEA Carcinoembryonic Antigen Gwajin
Carcinoembryonic Antigen (CEA)
CEA ita ce tantanin halitta glycoprotein tare da kimanin nauyin kwayoyin halitta na 20,000. Binciken da aka yi ya nuna cewa CEA na iya kasancewa a cikin nau'o'in cututtuka daban-daban fiye da ciwon daji na launi, ciki har da pancreatic, ciki, huhu, da nono, da sauransu. An kuma nuna ƙananan adadin a ɓoye daga mucosa na mallaka.
Tsayawa mai tsayi a cikin kewaya CEA biyowa magani yana nuna ƙarfi sosai ga ɓoyayyen metastatic da/ko saura cuta. Ƙimar CEA mai ci gaba mai tasowa na iya haɗawa da cutar da ke ci gaba da rashin lafiya. Sabanin haka, raguwar darajar CEA gabaɗaya tana nuni ne ga kyakkyawan hasashen da kuma kyakkyawar amsa ga jiyya.
An nuna ma'auni na CEA don dacewa da asibiti a cikin kulawa da kulawa da marasa lafiya tare da launi, nono, huhu, prostate, pancreatic, ovarian, da sauran carcinomas. Binciken da aka biyo baya na marasa lafiya masu launin launi, nono, da carcinomas na huhu sun nuna cewa matakin CEA na farko yana da mahimmanci.
Ba a ba da shawarar gwajin CEA azaman hanyar nunawa don gano ciwon daji a cikin yawan jama'a ba; duk da haka, yin amfani da gwajin CEA a matsayin gwajin haɗin gwiwa a cikin tsinkaye da kuma kula da masu ciwon daji an yarda da su sosai.
Matsakaicin matakin ganowa shine 5 ng/ml.

